Skip to content
Trial Eligibility
Menu

Alzheimer's Disease Clinical Trials near Houston, TX

20 studies for Alzheimer's Disease are recruiting at 27 sites within 50 miles of Houston, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Alzheimer's Disease trials in the US or all trials near Houston.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Alzheimer's Disease studies enrolling near Houston

Showing 20 studies, nearest first.
  1. ACP-204 in Adults With Alzheimer's Disease Psychosis

    NCT06159673

    • Phase 2/3
    • Ages 55 to 95 years
    • Sex: All

    Nearest sites: Clinical Trial Network LLC (Houston, TX); Kaleidoscope Clinical Research (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  2. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    NCT05980949

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest sites: Clinical Trial Network - 7080 Southwest Fwy (Houston, TX); Horizon Clinical Research: Gill Neuroscience (Cypress, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    NCT07177352

    • Phase 3
    • Ages 50 to 90 years
    • Sex: All

    Nearest sites: Re:Cognition Health - Houston (Houston, TX); Mt.Olympus Medical Research (Katy, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

    NCT05511363

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: Clinical Trial Network - 7080 Southwest Fwy (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease

    NCT05582200

    • Observational
    • Ages 18 to 90 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Houston Methodist Research Institute (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. Stem Cell Therapy for Early Alzheimer's Disease

    NCT06775964

    • Phase 1/2
    • Ages 60 to 80 years
    • Sex: All

    Nearest site: The University of Texas Health Science Center at Houston (UTHealth) (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Open-label Extension Study in Participants With Early Alzheimer's Disease

    NCT07105709

    • Phase 2
    • Ages 50 to 85 years
    • Sex: All

    Nearest site: GSK Investigational Site (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Epidemiology and Biomarker Study in Alzheimer's Disease

    NCT07142954

    • Phase 3
    • Ages 55 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Care Access - Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Phosphorylated Tau Levels in Donated Blood

    NCT07157839

    • Observational
    • Ages Any age
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: University of Texas Health Science Center at Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    NCT07589595

    • Phase 2
    • Ages 55 to 85 years
    • Sex: All

    Nearest site: The University of Texas Health Science Center at Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    NCT07602582

    • Phase 3
    • Ages 55 years and older
    • Sex: All

    Nearest site: The University of Texas Health Science Center at Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

    NCT07651319

    • Phase 1/2
    • Ages 50 to 86 years
    • Sex: All

    Nearest site: Houston Methodist Research Institute (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE

    NCT07667478

    • Interventional
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: Baylor College of Medicine (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

    NCT06126224

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: Local Institution - 1106 (Cypress, TX)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

    NCT06540833

    • Phase 2
    • Ages 55 years and older
    • Sex: All

    Nearest site: Horizon Clinical Research Group (Cypress, TX)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    NCT06808984

    • Phase 2
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: Horizon Clinical Research Center - Houston (Cypress, TX)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

    NCT07011745

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: Horizon Clinical Research Center - Houston (Cypress, TX)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    NCT07033494

    • Phase 2
    • Ages 50 to 85 years
    • Sex: All

    Nearest site: Horizon Clinical Research Center - Houston ( Site 1026) (Cypress, TX)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

    NCT07633470

    • Phase 4
    • Ages 50 years and older
    • Sex: All

    Nearest site: Mt. Olympus Medical Research, Llc - Katy (Katy, TX)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining an Alzheimer's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.